Aspiration system for peripheral thrombectomy launched after FDA clearance
Penumbra announced that it has launched its next-generation aspiration system for peripheral thrombectomy, which received FDA clearance in June.

The new system (Indigo System Lightning 12) combines an aspiration catheter with an intelligent aspiration system, enabling use of a clot detection mechanism to optimize thrombus removal, according to a press release from the company.

“Penumbra continues to lead the field of clot management by bringing highly innovative technology to address the challenges that we as physicians face while caring for our patients,” Frank R. Arko, MD, chief of the division of vascular and endovascular surgery at Sanger Heart and Vascular Institute, Atrium Health, said in the release. “When dealing with thrombus, we have learned that it is the combination of the catheter along with powered aspiration that yields the most effective results. Lightning 12 with Intelligent Aspiration is a giant leap forward for the field of thrombectomy, and we have been very impressed with the early results at Sanger.”